Footwear

Aokanginternational

Aokang International released FY2025 Q4 earnings on April 27, 2026, After-Market BJT: Actual Revenue CNY 444.33 M, Actual EPS CNY -0.0788

Aokang International released FY2026 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 426.79 M, actual EPS CNY 0.0633

Aokanginternational released FY2025 Annual Earnings on April 27 After-Market (BJT), Actual Revenue: CNY 1.924 B, Actual EPS: CNY -0.6011

Aokang International to Release FY2026 Q1 Earnings on April 28 After-Market (BJT)

Aokang International to Release FY2025 Annual Earnings on April 28, 2026 After-Market (BJT)

Aokang International released FY2025 Q3 earnings on October 30 After-Market (BJT), actual revenue CNY 398.56 M, actual EPS CNY -0.2927

Aokang International released FY2025 9 Months Earnings on October 30 After-Market (BJT), actual revenue CNY 1.479 B, actual EPS CNY -0.5222

Aokang International FY2025 Q3 Earnings Release on October 31, After-Market (BJT)

Aokanginternational released FY2025 Semi-Annual Earnings on August 22 Pre-Market (BJT), actual revenue CNY 1.081 B, actual EPS CNY -0.2295

Aokang International released FY2025 Q2 earnings on August 22 Pre-Market (BJT), actual revenue CNY 490.89 M, actual EPS CNY -0.1195

Aokanginternational to Release FY2025 Semi-Annual Earnings on August 23, 2025 (BJT)

Aokang International Redefines Comfort Standards Through Innovation and Brand Transformation

Aokang International Launches Comfortable Athletic Leather Shoes 3.0

Aoke Int'l Leads Footwear Industry Innovation

Aokang International Accelerates Digital Transformation in Footwear Industry

Aokang International Sees Profits Plummet in Q1 2025

Aokanginternational released FY2025 Q1 earnings on April 29 After-Market BJT, actual revenue CNY 589.72 M, actual EPS CNY -0.1099

Aokanginternational FY2025 Q1 Earnings Release Scheduled for April 30 After-Market BJT

Aokang International Net Loss Expanded to 216 Million Yuan in 2024

Aokanginternational released FY2024 earnings on April 15 After-Market BJT, actual revenue CNY 2.539 B, actual EPS CNY -0.538

603001

Aokang International announced that its operating revenue in the first half of 2025 was 1.081 billion yuan, a year-on-year decrease of 21.39%. The net loss attributable to shareholders of the listed company was 92.0448 million yuan, compared to a net loss of 19.8252 million yuan in the same period last year. The net cash flow generated from operating activities was 147 million yuan, a year-on-year increase of 42.34%

Zhitong

Aokang International: Net loss of 92.0448 million yuan in the first half of 2025

According to the Zhitong Finance APP, Aokang International announced that due to personal funding needs, the company's shareholder Xiang Jinyu intends to reduce his holdings in the company by 4 million shares and 8 million shares through centralized bidding and block trading, totaling no more than 12 million shares, which does not exceed 3% of the company's total share capital

Aokang International shareholder Xiang Jinyu plans to reduce his holdings by no more than 3%

Aokang International announced that the actual controller Wang Zhentao holds 15.10% of the company's shares, with a total pledge of 60 million shares, accounting for 99.08% of his shareholding. The controlling shareholder Aokang Investment and its concerted parties collectively hold 42.83% of the shares, with a total pledge of 111 million shares, accounting for 64.70% of their shareholding. Wang Zhentao pledged 26 million shares to Tianjin Trust, with the pledged financing used to supplement working capital. As of the announcement date, the controlling shareholder and concerted parties have cumulatively pledged 137 million shares, accounting for 34.19% of the company's total share capital

Aokang International: Controlling shareholder pledges 137 million shares

According to the Zhitong Finance APP, Aokang International released its first-quarter report for 2025, with a revenue of 590 million yuan in the first quarter, a year-on-year decrease of 22.30%; the net loss attributable to shareholders of the listed company was 44.0632 million yuan, turning from profit to loss; the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 48.2227 million yuan, turning from profit to loss; the basic loss per share was 0.1099 yuan/share

Aokang International released its first-quarter performance, reporting a net loss attributable to shareholders of 44.0632 million yuan, turning from profit to loss

Aokang International released its 2024 annual performance, with operating revenue of 2.539 billion yuan, a year-on-year decrease of 17.74%. The net loss attributable to shareholders was 216 million yuan, with losses widening. After deducting non-recurring gains and losses, the net loss was 261 million yuan, resulting in a basic loss per share of 0.5380 yuan. The company plans to distribute a cash dividend of 1.5 yuan (including tax) for every 10 shares

Aokang International released its 2024 annual performance, with a net loss attributable to the parent company of 216 million yuan, an expanded loss

On January 21, 2025, Aokang International held a board meeting to appoint Wang Chen to act as the Chairman and President, as Wang Zhentao and Wang Jinquan have resigned. This move ensures that the company's operational decisions proceed smoothly, with the acting responsibilities lasting until the new Chairman and President take office

Kanghua Biological

BOSIDENG

Weaver Network

Aokang International appoints director Wang Chen to act as chairman and president

According to the Zhitong Finance APP, Aokang International has released its performance forecast for 2024. The company expects to incur a loss in its annual operating performance for 2024, with a net loss attributable to the owners of the parent company of approximately 220 million yuan; it is expected that the net loss attributable to the owners of the parent company, after deducting non-recurring gains and losses, will be approximately 270 million yuan

Aokang International issues a profit warning, expecting an annual net loss of approximately 220 million yuan in 2024

002627

688139

Since the release of the "Six Guidelines for Mergers and Acquisitions" in September 2024, merger and acquisition activities in the A-share market have rapidly increased. However, recently, multiple companies have announced the termination of their merger and acquisition plans. Since December 2024, more than 10 companies, including HAIER BIOMEDICAL, Aokanginternational, and SXLY, have terminated related plans, indicating a trend dominated by market-driven reasons

SXLY

HAIER BIOMEDICAL

Chongbai

WILLING CORP.

The main reason is market-oriented, over 10 mergers and acquisitions have been terminated

Aokang International announced the termination of the additional issuance to acquire Lianhe Storage Technology (Jiangsu) Co., Ltd., as the parties involved failed to reach an agreement on the specific plan. The company stated that this decision is to protect the interests of all shareholders and will not affect the normal operation and development of the company. The company's stock will resume trading on January 8, 2025

Skychem Technology

Suochen

Tongxing

Aokang International terminates the additional issuance acquisition matter and resumes trading on January 8

Aokang International announced that its stock will resume trading on January 8, 2025, due to the termination of the issuance of shares to purchase assets. The stock has been suspended since December 24, 2024, originally planned to acquire equity in Lianhe Storage Technology Co., Ltd. through the issuance of shares and cash payment, but a final agreement could not be reached. The termination of this matter will not affect the company's normal operations, and the company will focus on enhancing profitability and core competitiveness while actively seeking external development paths

Aokang International: The company's stock will resume trading on January 8

Aokanginternational(603001.SH)